Amwill Health

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0U2L01017
  • NSEID:
  • BSEID: 544353
INR
35.50
0.00 (0.00%)
BSENSE

Feb 03

BSE+NSE Vol: 36000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -7.66% vs 45.69% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -30.09% vs 287.99% in Mar 2024

stock-summary

Interest

No Interest in the last few periods;

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -14.16% vs 301.36% in Mar 2024

Compare Profit and Loss Results of Amwill Health
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
40.00
50.00
-10.00
-20.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
40.00
50.00
-10.00
-20.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
37.00
-37.00
-100.00%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
7.00
1.00
6.00
600.00%
Operating Expenses
11.00
0.00
11.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
7.00
0.00
7.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
28.00
40.00
-12.00
-30.00%
Operating Profit (PBDIT) excl Other Income
11.00
10.00
1.00
10.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
12.00
10.00
2.00
20.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
12.00
9.00
3.00
33.33%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
11.00
9.00
2.00
22.22%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
11.00
9.00
2.00
22.22%
Provision for Tax
1.00
2.00
-1.00
-50.00%
Profit After Tax
10.00
7.00
3.00
42.86%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
17.00
11.00
6.00
54.55%
Profit Available for appropriations
27.00
18.00
9.00
50.00%
Appropriations
27.00
18.00
9.00
50.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
6.63
6.26
0.37
5.91%
Profit And Loss - Net Sales
Net Sales 40.58 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -7.66% vs 45.69% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.65 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -30.09% vs 287.99% in Mar 2024

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Interest in the last few periods;

Profit And Loss - Profit After Tax
Profit After Tax 10.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -14.16% vs 301.36% in Mar 2024